UBS raised the firm’s price target on Thermo Fisher (TMO) to $590 from $500 and keeps a Neutral rating on the shares. The firm’s forward view is unchanged after Q3 sales growth was about in-line with expectations and profitability beat, the analyst tells investors in a post-earnings note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher’s Mixed Financial Outlook: Hold Rating Amid Growth Challenges and Positive Adjustments
- Thermo Fisher price target raised to $620 from $530 at Deutsche Bank
- Thermo Fisher price target raised to $580 from $500 at Citi
- Thermo Fisher price target raised to $625 from $585 at Barclays
- Thermo Fisher Scientific Reports Strong Q3 2025 Results